Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Antibiotics (Basel, Switzerland)|April 3, 2021
Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future PerspectivesGiovanni Taccetti, Michela Francalanci, Giovanna Pizzamiglio, et al.
BMC Pulmonary Medicine|September 9, 2024
Clinical features and outcomes of persons with cystic fibrosis and nocardia isolation: a systematic reviewVito Terlizzi, Tommaso Ballerini, Alice Castaldo, et al.
American Journal of Infection Control|February 5, 2010
A 1-m distance is not safe for children with cystic fibrosis at risk for cross-infection with Pseudomonas aeruginosaFilippo Festini, Giovanni Taccetti, Valeria Galici, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|August 7, 2024
Cystic fibrosis-related chronic rhinosinusitis: the key role of a comprehensive evaluation in the era of highly effective modulator therapyAlberto Minzoni, Luca Mazzetti, Pietro Orlando, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 30, 2025
Prevalence and risk factors for recurrent Staphylococcus aureus small-colony variants in people with cystic fibrosis followed at the Tuscan Regional Reference CenterVito Terlizzi, Cristina Fevola, Daniela Dolce, et al.
Children (Basel, Switzerland)|November 11, 2022
Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case SeriesVito Terlizzi, Giuseppe Fabio Parisi, Beatrice Ferrari, et al.
Pediatric Pulmonology|October 31, 2008
Incidence of cystic fibrosis in the Albanian populationFilippo Festini, Giovanni Taccetti, Teresa Repetto, et al.
Orphanet Journal of Rare Diseases|September 13, 2024
CFTR modulators response of S737F and T465N CFTR variants on patient-derived rectal organoidsKarina Kleinfelder, Paola Melotti, Anca Manuela Hristodor, et al.
Therapeutic Advances in Respiratory Disease|February 11, 2025
Elexacaftor/tezacaftor/ivacaftor and inflammation in children and adolescents with cystic fibrosis: a retrospective dual-center cohort studyAngela Pepe, Cristina Fevola, Daniela Dolce, et al.
Pageof 9